Date & timeFriday, 29 January 2027 to 30 Jan
SectorHealthcare & Life Sciences
FormatIn-person
Event languageEnglish
About this event
A two-day multidisciplinary meeting on the shared disease processes and combined treatment of heart, kidney and metabolic disease, including SGLT2 inhibitors, GLP-1 receptor agonists and shared-care pathways.